✨ Free AI Report
Viz.ai, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Viz.ai, Inc.
Company Research

Viz.ai, Inc.: Business Overview, Financials & Competitive Analysis

Viz.ai, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Proven clinical platform achieving profitability with expanding pharma partnerships and multi-suite AI offerings driving acute care adoption and life sciences distribution at scale. Viz.ai has achieved profitability, secured $289M+ in funding, deployed over 50 FDA-cleared algorithms, and established strategic partnerships with leading pharma companies. Recent product launches (Pulmonary Suite in.

What is Viz.ai, Inc.'s industry? Viz.ai, Inc. (viz.ai) operates in Clinical AI & Drug Discovery. AskCyborg classifies Viz.ai, Inc. under Clinical AI & Drug Discovery in its company registry.

Viz.ai is a subscription SaaS company that provides AI-powered disease detection and care coordination solutions to hospitals and health systems. The company's platform leverages over 50 advanced, FDA-cleared algorith...

8/ 10Strong

Cyborg Score thesis

Proven clinical platform achieving profitability with expanding pharma partnerships and multi-suite AI offerings driving acute...

Read the full analyst-debate transcript →
Industry Clinical AI & Drug Discovery
3 named competitors
5 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 9, 2026
AI-Generated Research
30+ Page Report

Get the Latest Viz.ai, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Viz.ai, Inc.

AskCyborg analysts argue the bull and bear cases for Viz.ai, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Viz.ai, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Viz.ai, Inc. Overview

Pro stress-test →

Viz.ai is a subscription SaaS company that provides AI-powered disease detection and care coordination solutions to hospitals and health systems. The company's platform leverages over 50 advanced, FDA-cleared algorithms to analyze a range of imaging modalities—including CT scans, EKGs, and echocardiograms—providing automated assessments that accelerate diagnosis, streamline clinical workflows, and enable faster treatment decisions. As of January 2026, the company has reached profitability in its healthcare business.

Strategic Profile

Pro stress-test →

The Viz.ai platform includes several specialized solutions such as Viz.ai One™, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, Viz Trauma Suite, Viz Radiology Suite, and Viz Life Sciences. This business doubled over the prior 18 months to reach 13 strategic partnerships, with 6 new pharma partnerships added in 2025 alone, allowing pharmaceutical companies to accelerate product launches and improve patient access to new therapies. The company has established multi-year partnerships with major pharmaceutical companies to deploy disease-specific AI workflows, including Sanofi and Regeneron for AI-powered COPD workflows and Novartis for oncology workflows.

Competitive Landscape

Pro stress-test →

Viz.ai's top competitors include Medidata, IQVIA and Verily. Viz.ai differentiates through broad FDA-cleared algorithm portfolio, integrated care coordination platform, and proven clinical outcomes. The company's profitability status and pharma partnerships position it ahead of venture-backed competitors still scaling clinical adoption.

Industry Context

Viz.ai, Inc. operates in Clinical AI & Drug Discovery.

Key facts

Founded: 2016 · Headquarters: San Francisco, US · Employees: Not disclosed · Revenue: Not disclosed

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Viz.ai, Inc..

  • (May 2026) Launched Viz Pulmonary Suite, first comprehensive AI-powered solution dedicated to pulmonary care delivery
  • (March 2026) Real-world data showed 44% reduction in door-in-door-out transfer time for LVO stroke patients and 84% reduction in CTA-to-detection time
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Launched Viz Pulmonary Suite for pulmonary care delivery
  • May 2026Achieved ISO/IEC 42001 Certification, setting standard for Agentic AI in healthcare
  • +3 moreTrack every material event for Viz.ai, Inc. as it happens. Explore monitoring →
Get alerted when Viz.ai, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Medidata PlatformClinical trial and life sciences data platform→IQVIA PlatformClinical research and healthcare intelligence services→Verily Health AIHealthcare AI and clinical decision support→

Compare Viz.ai, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Viz.ai, Inc. operates in Clinical AI & Drug Discovery. See how the rest of the sector scores on the Cyborg framework.

Browse Clinical AI & Drug Discovery research →
NEW · MCP server

Ask your AI assistant about Viz.ai, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Viz.ai, Inc. and its top competitor on Cyborg Score”
“What did Viz.ai, Inc. do this quarter?”
“Is Viz.ai, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Viz.ai, Inc. do?+
Viz.ai is a subscription SaaS company that provides AI-powered disease detection and care coordination solutions to hospitals and health systems. The company's platform leverages over 50 advanced, FDA-cleared algorith...
What is Viz.ai, Inc.'s Cyborg Score?+
Viz.ai, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Viz.ai, Inc.'s main competitors?+
Named competitors include Medidata Platform, IQVIA Platform, Verily Health AI. The full competitive landscape is in the AskCyborg report.
How can I get the full Viz.ai, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Viz.ai, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Viz.ai, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.